Global markets have recently experienced a positive shift, driven by the U.S.-China tariff suspension and cooling inflation rates, which have bolstered investor confidence. While major indices are showing gains, attention is turning to lesser-known opportunities that may offer substantial growth potential. Penny stocks, despite being an older term in the investment lexicon, continue to represent promising prospects for those willing to explore smaller or newer companies with solid financial foundations.
Top 10 Penny Stocks Globally
| Name | Share Price | Market Cap | Rewards & Risks |
| CNMC Goldmine Holdings (Catalist:5TP) | SGD0.40 | SGD162.12M | ✅ 4 ⚠️ 3 View Analysis > |
| Yangzijiang Shipbuilding (Holdings) (SGX:BS6) | SGD2.20 | SGD8.66B | ✅ 5 ⚠️ 0 View Analysis > |
| Angler Gaming (NGM:ANGL) | SEK3.74 | SEK280.44M | ✅ 5 ⚠️ 2 View Analysis > |
| SKP Resources Bhd (KLSE:SKPRES) | MYR1.04 | MYR1.62B | ✅ 5 ⚠️ 1 View Analysis > |
| NEXG Berhad (KLSE:NEXG) | MYR0.375 | MYR1.09B | ✅ 4 ⚠️ 3 View Analysis > |
| Lever Style (SEHK:1346) | HK$1.19 | HK$750.83M | ✅ 4 ⚠️ 2 View Analysis > |
| Goodbaby International Holdings (SEHK:1086) | HK$1.27 | HK$2.19B | ✅ 4 ⚠️ 2 View Analysis > |
| Foresight Group Holdings (LSE:FSG) | £3.99 | £449.95M | ✅ 4 ⚠️ 1 View Analysis > |
| EZZ Life Science Holdings (ASX:EZZ) | A$1.55 | A$75.24M | ✅ 4 ⚠️ 2 View Analysis > |
| Bisalloy Steel Group (ASX:BIS) | A$3.37 | A$158.96M | ✅ 3 ⚠️ 1 View Analysis > |
Click here to see the full list of 5,618 stocks from our Global Penny Stocks screener.
Let's uncover some gems from our specialized screener.
Majestic Dragon AeroTech Holdings (SEHK:918)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Majestic Dragon AeroTech Holdings Limited is an investment holding company involved in the wholesale of timepieces, accessories, and garment and sportswear products across the People’s Republic of China, Taiwan, Hong Kong, and Africa with a market cap of HK$857.83 million.
Operations: Majestic Dragon AeroTech Holdings generates revenue primarily from its Unmanned Aerial Vehicles Business, which accounts for HK$129.08 million, and Property Investment, contributing HK$2.95 million.
Market Cap: HK$857.83M
Majestic Dragon AeroTech Holdings, with a market cap of HK$857.83 million, primarily generates revenue from its Unmanned Aerial Vehicles business (HK$129.08 million) and Property Investment (HK$2.95 million). Despite being unprofitable and having increased losses over the past five years, the company has a satisfactory net debt to equity ratio of 4.9% and sufficient cash runway for over three years due to positive free cash flow growth. However, both its board and management team are relatively inexperienced with an average tenure of 1.8 years, which may impact strategic decision-making moving forward.
- Get an in-depth perspective on Majestic Dragon AeroTech Holdings' performance by reading our balance sheet health report here.
- Review our historical performance report to gain insights into Majestic Dragon AeroTech Holdings' track record.
Palm Eco-Town Development (SZSE:002431)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Palm Eco-Town Development Co., Ltd focuses on the design, planning, construction, and operation of eco-towns in China with a market cap of CN¥3.59 billion.
Operations: The company generates CN¥2.87 billion in revenue from its operations within China.
Market Cap: CN¥3.59B
Palm Eco-Town Development Co., Ltd, with a market cap of CN¥3.59 billion, is currently unprofitable and has seen its losses deepen over the past five years. The company's revenue for 2024 was CN¥3.06 billion, down from CN¥4.05 billion in the previous year, while net loss increased to CN¥1.58 billion from CN¥939.89 million. Despite these challenges, it maintains a positive free cash flow and sufficient cash runway for more than three years but faces liquidity issues as short-term liabilities exceed short-term assets by CN¥3.7 billion. The management team is experienced with an average tenure of 2.3 years.
- Click to explore a detailed breakdown of our findings in Palm Eco-Town Development's financial health report.
- Gain insights into Palm Eco-Town Development's past trends and performance with our report on the company's historical track record.
Zhejiang Sunflower Great Health (SZSE:300111)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Zhejiang Sunflower Great Health Co., Ltd. operates in the health industry and has a market cap of CN¥3.95 billion.
Operations: The company generates revenue from the Pharmaceutical Industry segment, totaling CN¥318.91 million.
Market Cap: CN¥3.95B
Zhejiang Sunflower Great Health Co., Ltd. has a market cap of CN¥3.95 billion and operates in the health industry, generating CN¥318.91 million in revenue from its pharmaceutical segment. Despite being debt-free and having short-term assets of CN¥775.1 million that comfortably cover both short-term and long-term liabilities, the company reported a net loss for Q1 2025 with sales declining to CN¥72.23 million from the previous year’s figures. The management team is seasoned, averaging 8.6 years of tenure, yet recent earnings growth has been negative with profit margins dropping significantly from last year’s levels due to large one-off items impacting results.
- Dive into the specifics of Zhejiang Sunflower Great Health here with our thorough balance sheet health report.
- Assess Zhejiang Sunflower Great Health's previous results with our detailed historical performance reports.
Make It Happen
- Click through to start exploring the rest of the 5,615 Global Penny Stocks now.
- Ready For A Different Approach? The end of cancer? These 23 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Zhejiang Sunflower Great Health might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com